Skip to main content

1 Result(s)

within Joo Yoon Bae Remove this filter English Remove this filter

and

  1. Article

    Open Access

    Facial erythema after the treatment of dupilumab in SLE patient

    Dupilumab is a receptor antagonist binding to the alpha subunit of the interleukin-4 receptor. Through binding to it, dupilumab inhibits signaling of both IL-4 and IL-13, the representative Th2 biomarkers. Rec...

    Dong Hyek Jang, Jae In Lee, Joo Yoon Bae… in Allergy, Asthma & Clinical Immunology (2020)

    Download PDF (802 KB) View Article